Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

Summary: SARS-CoV-2 variants evade current monoclonal antibody therapies. Bispecific antibodies (bsAbs) combine the specificities of two distinct antibodies taking advantage of the avidity and synergy provided by targeting different epitopes. Here we used controlled Fab-arm exchange to produce bsAbs...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Laura Radić, Kwinten Sliepen, Victor Yin, Mitch Brinkkemper, Joan Capella-Pujol, Angela I. Schriek, Jonathan L. Torres, Sandhya Bangaru, Judith A. Burger, Meliawati Poniman, Ilja Bontjer, Joey H. Bouhuijs, David Gideonse, Dirk Eggink, Andrew B. Ward, Albert J.R. Heck, Marit J. Van Gils, Rogier W. Sanders, Janke Schinkel
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2023-04-01
Sarja:iScience
Aiheet:
Immunology
Virology
Structural biology
Linkit:http://www.sciencedirect.com/science/article/pii/S258900422300617X

Internet

http://www.sciencedirect.com/science/article/pii/S258900422300617X

Samankaltaisia teoksia